首页> 外文期刊>Toxicologic pathology >Toxicologic Pathology Forum*: Opinion on Integrating Innovative Digital Pathology Tools in the Regulatory Framework
【24h】

Toxicologic Pathology Forum*: Opinion on Integrating Innovative Digital Pathology Tools in the Regulatory Framework

机译:毒理学病理论坛*:关于整合创新数字病理工具在监管框架中的意见

获取原文
获取原文并翻译 | 示例
           

摘要

Digital pathology is defined as the ability to examine digitized microscopic slides and to generate qualitative and quantitative data. The field of digital pathology is rapidly evolving and has the potential to revolutionize toxicologic pathology. Techniques such as automated 2-D image analysis, whole slide imaging, and telepathology are already considered "mature" technologies and have been used for decades in exploratory studies; however, many organizations are reluctant to use digital pathology in regulatory toxicology studies. Innovative technologies using digitized slides including high-content imaging modalities and artificial intelligence are still under development but are increasingly used in toxicologic pathology. While software validation requirements are already described, clear guidance for application of these rules to the digital pathology field are few and the acceptance of these technologies by regulatory authorities remains necessary for successful adoption of digital pathology into the mainstream of toxicologic pathology. This topic was discussed during a roundtable at the 2018 Annual Congress of the French Society of Toxicologic Pathology. This opinion article summarizes the discussion regarding the current questions and challenges on the integration of innovative digital pathology tools within a good laboratory practice framework and is meant to stimulate further discussion among the toxicologic pathology community.
机译:数字病理学被定义为检查数字化显微载玻片的能力并生成定性和定量数据。数字病理学领域正在快速发展,有可能彻底改变毒理病理学。自动2-D图像分析,整个幻灯片成像和远程传神等技术已经被认为是“成熟”的技术,并且已在探索性研究中使用数十年;然而,许多组织不愿在监管毒理学研究中使用数字病理学。使用数字化载玻片的创新技术,包括高内容成像方式和人工智能仍在开发中,但越来越多地用于毒理病理学。虽然已经描述了软件验证要求,但对数字病理领域的应用,将这些规则的清除指导很少,并通过监管机构接受这些技术仍然是成功通过数字病理到毒理病理学的主流所必需的。在2018年法国毒理学病理学会的2018年度大会上讨论了这一主题。本文概述了关于在良好的实验室实践框架内纳入创新数字病理工具的当前问题和挑战的讨论,并旨在刺激毒理病理学界的进一步讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号